Green Valley Investors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$130M |
| 2 |
Linde
LIN
|
+$33M |
| 3 |
Amazon
AMZN
|
+$24.1M |
| 4 |
Merck
MRK
|
+$14.5M |
| 5 |
Intuitive Surgical
ISRG
|
+$9.64M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$292M |
| 2 |
Walt Disney
DIS
|
+$88.8M |
| 3 |
PX
Praxair Inc
PX
|
+$38.4M |
| 4 |
CELG
Celgene Corp
CELG
|
+$24M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$14.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.79% |
| 2 | Consumer Discretionary | 30.78% |
| 3 | Materials | 9.44% |
| 4 | Consumer Staples | 5.48% |
| 5 | Utilities | 0.44% |
Similar funds
Green Valley Investors's Q4 2018 Portfolio in Review
As of Q4 2018, Green Valley Investors held 36 positions worth $1.74B, down 22% from $2.24B the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Green Valley Investors withdrew a net $235M in Q4 2018, closing 4 positions and reducing 21 holdings. Its most notable exit was Express Scripts Holding Company, an estimated $292M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 54% of assets, down from 55% a quarter earlier, followed by Consumer Discretionary and Materials.
Against the trend, Green Valley Investors opened a new position in Cigna worth $118M.
- Green Valley Investors's largest Q4 2018 buy was Cigna: 623,322 shares worth $118M.
- Green Valley Investors added most to Amazon in Q4 2018, an estimated $24.1M increase.
- Green Valley Investors's biggest Q4 2018 reduction was Celgene Corp, cutting an estimated $24M.
- Green Valley Investors fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $292M.
- Green Valley Investors's ten largest holdings make up 58% of its $1.74B portfolio in Q4 2018.
- Green Valley Investors opened 4 new positions and closed 4 in Q4 2018.
- Green Valley Investors's portfolio value fell 22% quarter-over-quarter to $1.74B.
Based on Green Valley Investors's 13F filing for Q4 2018, filed 13 Feb 2019.